Jinlu Shan

Donafenib Versus Sorafenib in First-Line Treatment of Unresectable or Metastatic Hepatocellular Carcinoma: A Randomized, Open-Label, Parallel-Controlled Phase II-III Trial

Shukui Qin, Feng Bi, Shanzhi Gu et al. · Journal of Clinical Oncology · 2021 · 414 citations · Full text

Pharmacy, Oncology, Pharmacology +14

Perioperative Toripalimab Plus Chemotherapy for Patients With Resectable Non–Small Cell Lung Cancer

Shun Lü, Wei Zhang, Lin Wu et al. · JAMA · 2024 · 336 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Nanogold-enwrapped graphene nanocomposites as trace labels for sensitivity enhancement of electrochemical immunosensors in clinical immunoassays: Carcinoembryonic antigen as a model

Zhaoyang Zhong, Dong Wang, Dan Wang et al. · Biosensors and Bioelectronics · 2010 · 205 citations

Engineering, Materials Engineering, Materials Science +17

Perioperative toripalimab + platinum-doublet chemotherapy vs chemotherapy in resectable stage II/III non-small cell lung cancer (NSCLC): Interim event-free survival (EFS) analysis of the phase III Neotorch study.

Shun Lü, Lin Wu, Wei Zhang et al. · Journal of Clinical Oncology · 2023 · 88 citations

Medicine, Perioperative Medicine, Pharmacology +13

Association of genetic and immuno-characteristics with clinical outcomes in patients with RET-rearranged non-small cell lung cancer: a retrospective multicenter study

Chang Lu, Xiaorong Dong, Jun Zhao et al. · Journal of Hematology & Oncology · 2020 · 55 citations · Full text

Medicine, Molecular Genetics, Oncology +17